Ozempic, public health, and black markets - Listen - The Lancet

Ozempic, public health, and black markets

Listen now

Description

Gavin and Jessamy are joined by Oksana Pyzik (UCL, Fight The Fakes Alliance) to discuss how Ozempic/Wegovy/semaglutide works, what becoming mainstream means for our understanding of obesity and public health, and how demand is fuelling an unregulated black market in the drugs.Send us your feedback!Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/th...

More Episodes

See all »

Reducing premature deaths, the limits of human longevity, and healthy cities

Gavin, Richard, and Jessamy get into the studio for another bonus episode looking at the launch of the Global Health 2050 report at the World Health Summit in Berlin, a report which shows a path to cutting premature mortality by 50% by 2050. Also up for discussion are the limits of human...

Published 10/29/24

The Lancet Voice

Published 10/29/24

Poverty and health in the US

The US is the richest country in the world, but has some of the most entrenched poverty and associated poor health outcomes. Miriam Sabin (North American Senior Executive Editor at The Lancet) joins Jessamy to chat with Luke Shaefer (Professor of Public Policy at the University of Michigan and...

Published 10/24/24